Infectious Diseases Society: Newer Therapy Recommended for Treatment-Refractory Mac Pulmonary Inefection
July 07, 2020
July 07, 2020
ARLINGTON, Virginia, July 7 -- The Infectious Diseases Society of America issued the following news release:
A newer therapy that acts like a Trojan horse to attack bacteria should be reserved for patients with certain treatment-refractory lung infections, according to updated nontuberculous mycobacterial (NTM) pulmonary disease guidelines released by the Infectious Diseases Society of America (IDSA), the American Thoracic Society (ATS), the European Respiratory Society (ERS) and th . . .
A newer therapy that acts like a Trojan horse to attack bacteria should be reserved for patients with certain treatment-refractory lung infections, according to updated nontuberculous mycobacterial (NTM) pulmonary disease guidelines released by the Infectious Diseases Society of America (IDSA), the American Thoracic Society (ATS), the European Respiratory Society (ERS) and th . . .